A Trial Of Radioimmunotherapy, Reduced-Dose External Beam Craniospinal Radiation Therapy With IMRT Boost, And Chemotherapy For Patients With Standard-Risk Medulloblastoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Monoclonal antibody 3F8 I-131 (Primary) ; Cisplatin; Lomustine; Vincristine
- Indications Medulloblastoma
- Focus Therapeutic Use
- 23 Feb 2018 Planned End Date changed from 1 Feb 2018 to 1 Feb 2019.
- 23 Feb 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
- 13 Mar 2017 Planned End Date changed from 1 Feb 2017 to 1 Feb 2018.